These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunomodulator effects on the Friend virus infection in genetically defined mice. Sidwell RW; Morrey JD; Okleberry KM; Burger RA; Warren RP Ann N Y Acad Sci; 1993 Jun; 685():432-46. PubMed ID: 8363251 [TBL] [Abstract][Full Text] [Related]
6. Imexon and biological response modifiers in murine models of AIDS. Chirigos MA; Ussery MA; Black PL Int J Immunopharmacol; 1991; 13 Suppl 1():33-41. PubMed ID: 1823906 [TBL] [Abstract][Full Text] [Related]
8. Antiviral efficacy of Imexon in the Rauscher murine retrovirus AIDS model. Chirigos MA; Ussery MA; Rankin JT; Herrmann D; Bicker U; Black PL Immunopharmacol Immunotoxicol; 1990; 12(1):1-21. PubMed ID: 1693633 [No Abstract] [Full Text] [Related]
9. Treatment of the murine, retrovirus-induced lymphoproliferative immunodeficiency disease (LP-BM5) in C57BL/10 mice with the immunomodulator Imexon. Funk CY; Eisman J; Hersh EM AIDS Res Hum Retroviruses; 1992 May; 8(5):633-8. PubMed ID: 1515214 [TBL] [Abstract][Full Text] [Related]
10. Early-initiated zidovudine therapy prevents disease but not low levels of persistent retrovirus in mice. Morrey JD; Okleberry KM; Sidwell RW J Acquir Immune Defic Syndr (1988); 1991; 4(5):506-12. PubMed ID: 2016687 [TBL] [Abstract][Full Text] [Related]
12. Protective influence of lactoferrin on mice infected with the polycythemia-inducing strain of Friend virus complex. Lu L; Hangoc G; Oliff A; Chen LT; Shen RN; Broxmeyer HE Cancer Res; 1987 Aug; 47(15):4184-8. PubMed ID: 3038309 [TBL] [Abstract][Full Text] [Related]
13. Effect of the combination of interferon-alpha and stavudine on Friend virus infections in (B10.A x A.By)F1 mice. Sidwell RW; Warren RP; Okleberry K; Burger RA; Morrey JD J Infect Dis; 1995 Mar; 171 Suppl 2():S93-8. PubMed ID: 7861024 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of genetic resistance to friend virus leukemia in mice. Kumar V; Bennett M; Eckner RJ J Exp Med; 1974 May; 139(5):1093-109. PubMed ID: 4596510 [TBL] [Abstract][Full Text] [Related]
16. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice. Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370 [TBL] [Abstract][Full Text] [Related]
17. Impeded progression of Friend disease in mice by an inhibitor of retroviral proteases. Lai MH; Tang J; Wroblewski V; Dee AG; Margolin N; Vlahos C; Bowdon B; Buckheit R; Colacino J; Hui KY J Acquir Immune Defic Syndr (1988); 1993 Jan; 6(1):24-31. PubMed ID: 8093263 [TBL] [Abstract][Full Text] [Related]
18. Antiviral effect of N-phenylacetoaminomethylene-DL-p-nitrophenylalanine (A-101) on murine leukemia viruses. Fujita H; Sakurai T; Toyoshima S J Natl Cancer Inst; 1979 Mar; 62(3):565-8. PubMed ID: 283285 [TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of human lactoferrin and recombinant murine interferon-gamma on disease progression in mice infected with the polycythemia-inducing strain of the Friend virus complex. Lu L; Shen RN; Zhou SZ; Srivastava C; Harrington M; Miyazawa K; Wu B; Lin ZH; Ruscetti S; Broxmeyer HE Int J Hematol; 1991 Apr; 54(2):117-24. PubMed ID: 1660735 [TBL] [Abstract][Full Text] [Related]
20. Erythroleukemia induction by Friend leukemia virus. A host gene locus controlling early anemia or polycythemia and the rate of proliferation of late erythroid cells. Shibuya T; Niho Y; Mak TW J Exp Med; 1982 Aug; 156(2):398-414. PubMed ID: 7097158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]